Maria Aiello

Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia

Richard R. Furman, Jeff P. Sharman, Steven Coutré et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

A Phase 2 Study of Idelalisib Monotherapy in Previously Untreated Patients ≥65 Years with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

Andrew D. Zelenetz, Nicole Lamanna, Thomas J. Kipps et al. · Blood · 2014 · 29 citations

Medicine, Hematology, Oncology +10

A phase III, randomized, controlled study evaluating the efficacy and safety of idelalisib (GS-1101) in combination with ofatumumab for previously treated chronic lymphocytic leukemia (CLL).

Ian W. Flinn, Eva Kimby, Finbarr E. Cotter et al. · Journal of Clinical Oncology · 2013 · 20 citations

Life Sciences, Immunology, Pharmacology +17

Interim Analysis Of Dose-Escalation Stage Of a Phase 1b Study Evaluating Safety and Pharmacology Of GS-9820, a Second-Generation, Selective, PI3Kd-Inhibitor in Recurrent Lymphoid Malignancies

Arnon P. Kater, Sanne H. Tonino, Marie José Kersten et al. · Blood · 2013 · 13 citations

Medicine, Oncology, Pharmacology +10